Biotechnology
Home » Point-Of-Care Diagnostics / Testing (POCT) Market

Point-Of-Care Diagnostics / Testing (POCT) Market

Point-Of-Care Diagnostics / Testing (POCT) Market By Product (Glucose Monitoring, Cardiac Markers, Infectious Diseases Testing, Cholesterol Testing, Coagulation Monitoring, Pregnancy And Fertility Testing, Hematology Testing, Blood Gas Testing), By End-User (Clinics, Home, Laboratories, Assisted Living Healthcare Facilities, Hospitals) – Growth, Share, Opportunities & Competitive Analysis, 2022 – 2029
Report Book

Published Date: Apr. 2016
Category: Biotechnology
Report ID: 57804
Report Format: PDF
No of Pages: 190

Rating: Credence Reports

Market Insights

The point-of-care diagnostics/testing (POCT) report studies various products and end-user markets. POCT is considered one of the most affordable technologies of the global diagnostics market, and development in POCT technologies over a period of time has been carried out through innovations in smart and portable bio-sensor, computing, and information and communication technologies. According to market experts, the factors assisting the growth of the POC diagnostics market are several government initiatives that have aided in developing innovative outpatient care models to minimize hospital stays and rapidly increasing demand for home healthcare globally.

For the purpose of this study, the global point of care diagnostics market based on product type is segmented into glucose monitoring, urinalysis testing, cardiac markers, infectious diseases testing, cholesterol testing, coagulation monitoring, pregnancy and fertility testing, hematology testing, fecal occult testing kits, blood gas testing, cancer markers, drugs of abuse testing, and others. Market size estimates and forecasts for these segments for 2020 to 2029 are provided in terms of USD Mn and the respective compounded annual growth rates (CAGRs) for 2022 to 2029, considering 2021 as the base year.

Based on end-users point of care diagnostic market is segmented as clinics, homes, laboratories, assisted living healthcare facilities, and hospitals. The diagnostic tests performed on a large scale in these healthcare institutes and the increasing demand for further expansion of point-of-care diagnostic facilities are the key factors fueling the growth of point of care diagnostics market in hospitals and clinics. Therefore, market size estimates and forecasts for these segments for 2020 to 2029 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2022 to 2029, considering 2021 as the base year.

The POC diagnostics and testing market has been geographically categorized into major regions such as North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. Each geography market is further split to provide market revenue for select countries such as the U.S., Canada, U.K., Germany, China, Japan, Brazil, and GCC countries. Market size and forecast for these segments during 2020 to 2029 and their CAGRs for the period 2022 to 2029 are provided in this report.

The key manufacturers from the point-of-care diagnostics market are carrying out constant efforts and huge investments on the research and development of innovative products which are enabled with advanced technologies. The major key players profiled in the POC diagnostics and testing market are based on various characteristics such as business description, financial health and budget allocation, product portfolio, and news coverage. The key players profiled in this report are Roche Diagnostics Ltd., Alere Inc., Siemens AG, and Beckman Coulter, Inc., Johnson & Johnson, Bayer AG, and Abbott Laboratories, Abaxis, Inc., Becton, Dickinson And Company, and Nipro Diagnostics, Inc.

By Products

Based on the type of products, the global point-of-care diagnostics/testing (POCT) market is segmented as follows:

  • Glucose Monitoring
  • Cardiac Markers
  • Infectious Diseases Testing
  • Cholesterol Testing
  • Coagulation Monitoring
  • Pregnancy And Fertility Testing
  • Hematology Testing
  • Blood Gas Testing
  • Others (Fecal Occult Testing, Cancer Markers, Urinalysis Testing, Drugs Of Abuse Testing, etc.)

In year 2021, the glucose monitoring segment accounted for the largest market share in the POCT market. The incidences and prevalence of diabetes and the requirement of regular measurement of sugar levels in the blood are the key factors driving the point-of-care glucose monitoring market. According to International Diabetes Federation (IDF), the number of people living with the disease is expected to soar to 552 million by 2030 — equating to three new cases every 10 seconds — up from 366 million in 2011. However, the rapid diagnostics market and OTC is expected to show lucrative growth over the forecast period owing to the rising demand for early disease diagnosis and self-diagnosis to instigate immediate and on-time treatment of chronic diseases.

By End Users

Based on the end-users, the point-of-care diagnostics/testing (POCT) market is segmented into:

  • Clinics
  • Home
  • Laboratories
  • Assisted living healthcare facilities
  • Hospitals

In the base year 2021, the clinics and hospitals collectively attribute the largest share in the market in terms of revenue. This is because diagnostic tests are carried out on a large scale in these healthcare institutes, and the rising demand for accessible and patient-compliant diagnostics technologies are the key factors fueling the growth of the POC diagnostics market in hospitals and clinics. Moreover, with the aging patient base worldwide and the rising demand for assisted and home healthcare technologies, the point-of-care diagnostic market is expected to show lucrative growth over the forecast period 2022 – 2029.

By Geography

For the purpose of this study, the global point-of-care diagnostics or testing (POCT) market is categorized into:

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • France
    • UK.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of the Middle East and Africa

In the base year 2021, North America accounted for the largest share in the global POCT market, followed by Asia-Pacific, Europe, and the RoW (The rest of the World). The Asia-Pacific region (comprising Japan, China, and India as major countries) is anticipated to grow at the fastest CAGR during the forecast period 2022 – 2029. The key factors assisting the growth of the point-of-care diagnostics market in the Asia-Pacific region are the huge patient population base, the large number of R&D activities carried out in the diagnostics field, rising focus of both international and domestic players on the Asia-Pacific POCT market, and increasing funding/investment towards the development of Point-Of-Care Diagnostics / Testing products.

Chapter 1 Preface
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 Point-of-Care Diagnostics/Testing Market, by Product Type, 2021 (USD Mn)
2.2 Point-of-Care Diagnostics/Testing Market Share, by End Users, 2021 & 2029 (Value %)
2.3 Point-of-Care Diagnostics/Testing Market Share, by Geography, 2021 (Value %)

Chapter 3 Global Point-of-Care Diagnostics/Testing Market: Market Dynamics and Outlook
3.1 Point-of-Care Diagnostics/Testing : Current and Future Trends
3.2 Drivers
3.3 Challenges
3.4 Future Prospects
3.5 Attractive Investment Proposition
3.6 Market Share Analysis: Key Point-of-Care Diagnostics/Testing Manufacturers, 2021 (%)

Chapter 4 Global Point-of-Care Diagnostics/Testing Market Analysis, by Product Type
4.1 Preface
4.2 Glucose Monitoring
4.3 Cardiac Markers
4.4 Infectious Diseases Testing
4.5 Cholesterol Testing
4.6 Coagulation Monitoring
4.7 Pregnancy And Fertility Testing
4.8 Hematology Testing
4.9 Blood Gas Testing
4.10 Others

Chapter 5 Global Point-of-Care Diagnostics/Testing Market Analysis, by End-User
5.1 Preface
5.2 Clinics
5.3 Home
5.4 Laboratories
5.5 Assisted living healthcare facilities
5.6 Hospitals

Chapter 6 Global Point-of-Care Diagnostics/Testing Market, by Geography
6.1 Preface
6.2 North America
6.2.1 U.S
6.2.2 Canada
6.3 Europe
6.3.1 U.K
6.3.2 Germany
6.3.3 Rest of Europe
6.4 Asia Pacific
6.4.1 China
6.4.2 Japan
6.4.3 Rest of Asia Pacific
6.5 Latin America (LATAM)
6.5.1 Brazil
6.5.2 Mexico
6.5.3 Rest of LATAM
6.6 Middle East and Africa (MEA)

Chapter 7 Future Growth Advocacies

Chapter 8 Company Profiles
8.1 Abbott Laboratories, Inc.
8.1.1 Business Description
8.1.2 Financial Health and budget allocation
8.1.3 Product Positions/Portfolio
8.1.4 Key Competitors
8.1.5 News Coverage
8.2 Abaxis, Inc.
8.2.1 Business Description
8.2.2 Financial Health and Budget Allocation
8.2.3 Product Positions/Portfolio
8.2.4 Key Competitors
8.2.5 News Coverage
8.3 Alere, Inc.
8.3.1 Business Description
8.3.2 Financial Health and Budget Allocation
8.3.3 Product Positions/Portfolio
8.3.4 Key Competitors
8.3.5 News Coverage
8.4 Bayer AG
8.4.1 Business Description
8.4.2 Financial Health and budget allocation
8.4.3 Product Positions/
8.4.4 Key Competitors
8.4.5 News Coverage
8.5 Danaher Corporation
8.5.1 Business Description
8.5.2 Financial Health and budget allocation
8.5.3 Product Positions/Portfolio
8.5.4 Key Competitors
8.5.5 News Coverage
8.6 Becton, Dickinson And Company
8.6.1 Business Description
8.6.2 Financial Health and budget allocation
8.6.3 Product Positions/Portfolio
8.6.4 Key Competitors
8.6.5 News Coverage
8.7 Johnson & Johnson
8.7.1 Business Description
8.7.2 Financial Health and budget allocation
8.7.3 Product Positions/Portfolio
8.7.4 Key Competitors
8.7.5 News Coverage
8.8 Nipro Corporation
8.8.1 Business Description
8.8.2 Financial Health and budget allocation
8.8.3 Product Positions/Portfolio
8.8.4 Key Competitors
8.8.5 News Coverage
8.9 Roche Diagnostics Limited
8.9.1 Business Description
8.9.2 Financial Health and budget allocation
8.9.3 Product Positions/Portfolio
8.9.4 Key Competitors
8.9.5 News Coverage
8.10 Siemens Healthcare
8.10.1 Business Description
8.10.2 Financial Health and budget allocation
8.10.3 Product Positions/Portfolio
8.10.4 Key Competitors
8.4.5 News Coverage
8.11 Samsung Medison Co. Ltd.
8.11.1 Business Description
8.11.2 Financial Health and budget allocation
8.11.3 Product Positions/Portfolio
8.11.4 Key Competitors
8.11.5 News Coverage

List of Figures

FIG. 1 Point-of-Care Diagnostics / Testing : Market Segmentation
FIG. 2 Point-of-Care Diagnostics / Testing Market, by Product Type, 2021 (USD Mn)
FIG. 3 Point-of-Care Diagnostics / Testing Market Share, by End-Users, 2021 & 2029 (Value %)
FIG. 4 Point-of-Care Diagnostics / Testing Market Share, by Geography, 2021 (Value %)
FIG. 5 Attractive Investment Proposition, Point-of-Care Diagnostics / Testing Market, 2021
FIG. 6 Key Players Market Share Analysis for Point-of-Care Diagnostics / Testing, 2021(%)
FIG. 7 Global Glucose Monitoring Products Market Revenue, 2020 – 2029 (USD Mn)
FIG. 8 Global Cardiac MarkerProducts Market Revenue, 2020 – 2029 (USD Mn)
FIG. 9 Global Infectious Diseases Testing Products Market Revenue, 2020 – 2029 (USD
Mn)
FIG. 10 Global Cholesterol Testing Products Market Revenue, 2020 – 2029 (USD Mn)
FIG. 11 Global Coagulation Monitoring Products Market Revenue, 2020 – 2029 (USD Mn)
FIG. 12 Global Pregnancy and Fertility Testing Products Market Revenue, 2020 – 2029 (USD Mn)
FIG. 13 Global Hematology Testing Products Market Revenue, 2020 – 2029 (USD Mn)
FIG. 14 Global Blood Gas Testing Products Market Revenue, 2020 – 2029 (USD Mn)
FIG. 15 Global Other Products Market Revenue, 2020 – 2029 (USD Mn)
FIG. 16 Global Clinics in Point-of-Care Diagnostics/Testing Market Revenue, 2020 – 2029
(USD Mn)
FIG. 17 Global Home in Point-of-Care Diagnostics/Testing Market Revenue, 2020 – 2029 (USD
Mn)
FIG. 18 Global Laboratories in Point-of-Care Diagnostics/Testing Market Revenue, 2020 – 2029
(USD Mn)
FIG. 19 Global Assisted living healthcare facilities in Point-of-Care Diagnostics/Testing Market
Revenue, 2020 – 2029 (USD Mn)
FIG. 20 Global Hospitals in Point-of-Care Diagnostics/Testing Market Revenue, 2020 – 2029 (USD
Mn)

List of Tables

TABLE 1 Global Point-of-Care Diagnostics/Testing Market Revenue, by Product Type, 2020 – 2029 (USD Mn)
TABLE 2 Global Point-of-Care Diagnostics/Testing Market Revenue, by Technology, 2020 – 2029 (USD Mn)
TABLE 3 Global Point-of-Care Diagnostics/Testing Market Revenue, by Geography, 2020 – 2029 (USD Mn)
TABLE 4 North America Point-of-Care Diagnostics/Testing Market Revenue, by Country, 2020 – 2029 (USD Mn)
TABLE 5 Europe Point-of-Care Diagnostics/Testing Market Revenue, by Country, 2020 – 2029 (USD Mn)
TABLE 6 Asia – Pacific Point-of-Care Diagnostics/Testing Market Revenue, by Country, 2020 – 2029 (USD Mn)
TABLE 7 Latin America Point-of-Care Diagnostics/Testing Market Revenue, by Country, 2020 – 2029 (USD Mn)
TABLE 8 Middle East and Africa Point-of-Care Diagnostics/Testing Market Revenue, by Region, 2020 – 2029 (USD Mn)

Frequently Asked Questions

What is the size of Point-Of-Care Diagnostics / Testing Market?

The market for Point-Of-Care Diagnostics / Testing is expected to reach USD XX Mn in 2029

What is the Point-Of-Care Diagnostics / Testing Market CAGR?

The Point-Of-Care Diagnostics / Testing market is expected to see significant CAGR growth over the coming years, at XX%.

What is the Forecast period considered for Point-Of-Care Diagnostics / Testing Market?

The report is forecasted from 2022-2029

What is the base year considered for Point-Of-Care Diagnostics / Testing Market?

The base year of this report is 2021.

Who are the major players in this market?

Roche Diagnostics Ltd., Alere Inc., Siemens AG, and Beckman Coulter, Inc., Johnson & Johnson, Bayer AG, and Abbott Laboratories, Abaxis, Inc., Becton, Dickinson And Company, and Nipro Diagnostics, Inc. are some of the major players in the global market.

Biotechnology

Mass Spectrometry Market

Published Date: Aug. 2023
Category: Biotechnology
Report ID: 58466
Report Format: PDF
No of Pages: 246

Biotechnology

Aptamers Market

Published Date: Aug 2023
Category: Biotechnology
Report ID: 59152
Report Format: PDF
No of Pages: 240

Biotechnology

Biologic Imaging Reagents Market

Published Date: August 2023
Category: Biotechnology
Report ID: 62085
Report Format: PDF
No of Pages: 215

Biotechnology

Agriculture Biotechnology Market

Published Date: Aug 2023
Category: Biotechnology
Report ID: 62073
Report Format: PDF
No of Pages: 228

Biotechnology

Monoclonal Antibody Custom Service Market

Published Date: August 2023
Category: Biotechnology
Report ID: 62059
Report Format: PDF
No of Pages: 243

Biotechnology

Capsule Endoscope and Workstation Market

Published Date: Aug 2023
Category: Biotechnology
Report ID: 62054
Report Format: PDF
No of Pages: 225

Biotechnology

Cell Separation Technologies Market

Published Date: Aug 2023
Category: Biotechnology
Report ID: 62053
Report Format: PDF
No of Pages: 247

Biotechnology

DNA Probe-Based Diagnostics Market

Published Date: Aug 2023
Category: Biotechnology
Report ID: 62051
Report Format: PDF
No of Pages: 228

Biotechnology

Terpenes Market

Published Date: August 2023
Category: Biotechnology
Report ID: 60946
Report Format: PDF
No of Pages: 166

Biotechnology

Cell Isolation And Separation Market

Published Date: July 2023
Category: Biotechnology
Report ID: 59149
Report Format: PDF
No of Pages: 224

Biotechnology

Biological Product Manufacturing Market

Published Date: July 2023
Category: Biotechnology
Report ID: 61994
Report Format: PDF
No of Pages: 232

Biotechnology

Mobile Water Treatment Systems Market

Published Date: July 2023
Category: Biotechnology
Report ID: 61323
Report Format: PDF
No of Pages: 232

Download Sample Report


Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN
WhatsApp Now